Predictors of post-cancer diagnosis resignation among Japanese cancer survivors
In Japan, due to the increased incidence of cancer among the working population, it has become more important to support employees to achieve a balance between cancer treatment and work. This study aimed to clarify the predictors of resigning from employment after being diagnosed with cancer (post-cancer diagnosis [PCD] resignation) among Japanese employees.
As part of a Japanese national research project (Endo-Han), the investigators conducted a web-based survey of cancer survivors (CSs) in 2017. The investigators analyzed the risk factors for PCD resignation using a logistic regression model, including age at diagnosis, sex, cancer type, cancer stage, year of diagnosis, whether the patient held a managerial role, type of employment, and company size.
Of 750 employed Japanese CSs, 93 (12.4%) resigned from their jobs. The non-managers resigned more often (14.6%) than the managers (7.6%) (p = 0.007). The temporary workers exhibited the highest PCD resignation rates (22.2%), while the PCD resignation rates of the self-employed workers and permanent workers were 15.2% and 7.6%, respectively (p < 0.001). As the result of multivariate analysis, being female (odds ratio [OR], 3.67; 95%CI, 1.71–7.87), having hematological cancer (OR, 4.23; 95%CI, 1.37–13.04), having advanced cancer (OR, 2.48; 95%CI, 1.52–4.03), and being a temporary worker (OR, 2.51; 95%CI, 1.40–4.50) were identified as predictors of PCD resignation.
In total, 12.4% of Japanese employees quit their jobs after being diagnosed with cancer. Being female or a temporary worker and having advanced cancer were identified as predictors of PCD resignation. Regarding cancer type, hematological cancer was most strongly associated with PCD resignation.
Implication of Cancer Survivors
CSs who are females and temporary workers and have advanced cancer should be followed-up more carefully after cancer diagnosis for their work sustainability, by medical professionals, companies, and society.
KeywordsCancer survivors (CSs) Japanese employees Post-cancer diagnosis (PCD) resignation Cancer site Employment
This study was funded by grants from the Japanese Ministry of Health, Labour and Welfare (Research Grant: Gan-taisaku-ippan-012) to Motoki Endo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflicts of interest.
- 5.Ministry of Health L, Welfare, Japan. Report of Japanese goverment comittee for work support among Japanese cancer survivors “Gankanja keikensya no syurousien no arikata ni kansuru kentoukai houkokusyo” (in Japanese). 2014.Google Scholar
- 6.National Cancer Center J. Cancer registry and statistics. Cancer information service. 2014.Google Scholar
- 8.Endo M, Haruyama Y, Takahashi M, Nishiura C, Kojimahara N, Yamaguchi N. Returning to work after sick leave due to cancer: a 365-day cohort study of Japanese cancer survivors. J Cancer Surviv. 2015.Google Scholar
- 9.Ministry of Health Labor W, Japan. Jigyojou ni okeru tiryo to syokugyouseikatu ni okeru ryouritusien ni okeru gaidorain (Guideline for support for therapy and work life in Japanese workforce). 2016.Google Scholar
- 20.Ministry of Health L, Welfare, Japan. Labor Contract Act. Ministry of Health, Labor, Welfare, Japan; 2007.Google Scholar
- 33.Ministry of Internal Affairs and Communications J. Survey on time use and leisure activities “Syakaiseikatsukihontyosa” (in Japanese). 2016.Google Scholar
- 36.Joachim Weis MH. Cancer-related fatigue. 2015.Google Scholar
- 37.Hematology JSo. The clinical guideline of haematological malignancies (in Japanese). 2018.Google Scholar
- 42.Paltrinieri S, Vicentini M, Mazzini E, Ricchi E, Fugazzaro S, Mancuso P, et al. Factors influencing return to work of cancer survivors: a population-based study in Italy. Support Care Cancer. 2019.Google Scholar
- 43.Statistic Bureau MoIAaC, Japan. Statistical handbook of Japan. 2018.Google Scholar